Who owns OCUPHIRE PHARMA INC?
- Ticker: IRD
- CUSIP Number: 67577r102
Tip: Access positions for across all investors
Analyze quarterly positions in Ocuphire Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ocuphire Pharma stock
Who bought or sold OCUPHIRE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 4.3M | $7.1M | 0% | Sep 2025 |
|
| BIOS Capital Management | 3.7M | $6.6M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 3.3M | $5.5M | 0% | Sep 2025 |
|
| Vanguard Group | 1.3M | $2.2M | 35% | Sep 2025 |
|
| Mink Brook Asset Management | 1.2M | $2.0M | 100% | Sep 2025 |
|
| Opaleye Management | 1.1M | $1.8M | -10% | Sep 2025 |
|
| Adage Capital Partners GP | 955k | $1.6M | 100% | Sep 2025 |
|
| Bleichroeder | 737k | $1.2M | 0% | Sep 2025 |
|
| Voss Capital | 562k | $928k | 4% | Sep 2025 |
|
| Geode Capital Management | 469k | $774k | 32% | Sep 2025 |
|
| Renaissance Technologies | 174k | $287k | 13% | Sep 2025 |
|
| State Street Corporation | 146k | $241k | 107% | Sep 2025 |
|
| Creative Planning | 128k | $212k | 100% | Sep 2025 |
|
| Citadel Advisors | 113k | $187k | 497% | Sep 2025 |
|
| Two Sigma Investments | 108k | $179k | 170% | Sep 2025 |
|
| Northern Trust | 68k | $113k | 0% | Sep 2025 |
|
| XTX Topco | 52k | $85k | 227% | Sep 2025 |
|
| BlackRock | 46k | $76k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 42k | $69k | 0% | Sep 2025 |
|
| Empowered Funds | 42k | $69k | 0% | Sep 2025 |
|
| Simplex Trading | 33k | $54k | 100% | Sep 2025 |
|
| Captrust Financial Advisors | 32k | $53k | 0% | Sep 2025 |
|
| Morgan Stanley | 29k | $27k | 100% | Jun 2025 |
|
| William Blair $ Company | 25k | $40k | 0% | Sep 2025 |
|
| Raymond James Financial | 23k | $37k | 96% | Sep 2025 |
|
| Hrt Financial | 21k | $34k | 100% | Sep 2025 |
|
| Susquehanna International | 20k | $33k | 17% | Sep 2025 |
|
| Kestra Private Wealth Services | 19k | $31k | 0% | Sep 2025 |
|
| Two Sigma Securities | 18k | $29k | 100% | Sep 2025 |
|
| Financial Gravity Companies | 17k | $16k | 100% | Jun 2025 |
|
| James Investment Research | 16k | $27k | 0% | Sep 2025 |
|
| Goss Wealth Management | 16k | $27k | 0% | Sep 2025 |
|
| Bedel Financial Consulting | 15k | $25k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 14k | $24k | 0% | Sep 2025 |
|
| Prudential Financial | 13k | $22k | 100% | Sep 2025 |
|
| Stokes Family Office | 12k | $20k | 0% | Sep 2025 |
|
| Brian McDonald | 12k | $20k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 10k | $17k | 100% | Sep 2025 |
|
| Reliant Investment Partners | 10k | $19k | 0% | Sep 2025 |
|
| Annandale Capital | 10k | $165.000000 | 100% | Sep 2025 |
|
| Wells Fargo & Company | 3.8k | $6.2k | 0% | Sep 2025 |
|
| SBI Securities | 2.6k | $4.3k | -28% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 2.0k | $3.3k | 0% | Sep 2025 |
|
| Barclays | 1.9k | $3.1k | 0% | Sep 2025 |
|
| UBS Group | 884.00 | $1.5k | -97% | Sep 2025 |
|
| MAI Wealth Advisors | 123.00 | $202.999200 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 30.00 | $0 | -100% | Sep 2025 |
|
Who sold out of Ocuphire Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 128k | $120k |
| Virtu Financial | Jun 2025 | 79k | $75k |
| Financial Gravity Wealth | Mar 2025 | 17k | $16k |
| Tower Research Capital | Jun 2025 | 6.7k | $6.3k |
| CarsonAllaria Wealth Management | Jun 2025 | 1.0k | $942.000000 |
| Jpmorgan Chase & Co | Mar 2025 | 58.00 | $57.002400 |